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Abstract
Background: Microglial cells are important effectors of the neuronal innate immune system with a major role in
chronic neurodegenerative diseases. Curcumin, a major component of tumeric, alleviates pro-inflammatory activities
of these cells by inhibiting nuclear factor kappa B (NFkB) signaling. To study the immuno-modulatory effects of
curcumin on a transcriptomic level, DNA-microarray analyses were performed with resting and LPS-challenged
microglial cells after short-term treatment with curcumin.
Methods: Resting and LPS-activated BV-2 cells were stimulated with curcumin and genome-wide mRNA expression
patterns were determined using DNA-microarrays. Selected qRT-PCR analyses were performed to confirm newly
identified curcumin-regulated genes. The migration potential of microglial cells was determined with wound healing
assays and transwell migration assays. Microglial neurotoxicity was estimated by morphological analyses and
quantification of caspase 3/7 levels in 661W photoreceptors cultured in the presence of microglia-conditioned medium.
Results: Curcumin treatment markedly changed the microglial transcriptome with 49 differentially expressed transcripts
in a combined analysis of resting and activated microglial cells. Curcumin effectively triggered anti-inflammatory signals
as shown by induced expression of Interleukin 4 and Peroxisome proliferator activated receptor a. Several novel curcumin-
induced genes including Netrin G1, Delta-like 1, Platelet endothelial cell adhesion molecule 1, and Plasma cell endoplasmic
reticulum protein 1, have been previously associated with adhesion and cell migration. Consequently, curcumin
treatment significantly inhibited basal and activation-induced migration of BV-2 microglia. Curcumin also potently
blocked gene expression related to pro-inflammatory activation of resting cells including Toll-like receptor 2 and
Prostaglandin-endoperoxide synthase 2. Moreover, transcription of NO synthase 2 and Signal transducer and activator of
transcription 1 was reduced in LPS-triggered microglia. These transcriptional changes in curcumin-treated LPS-primed
microglia also lead to decreased neurotoxicity with reduced apoptosis of 661W photoreceptor cultures.
Conclusions: Collectively, our results suggest that curcumin is a potent modulator of the microglial transcriptome.
Curcumin attenuates microglial migration and triggers a phenotype with anti-inflammatory and neuroprotective
properties. Thus, curcumin could be a nutraceutical compound to develop immuno-modulatory and
neuroprotective therapies for the treatment of various neurodegenerative disorders.
Background
Microglial cells are resident macrophages of the nervous
system with pivotal roles in innate immune regulation and
neuronal homeostasis [1,2]. They are cells of the mono-
nuclear phagocyte lineage but their unique localization
within the nervous system and their morphological
features clearly distinguish them from other macrophage
populations [3]. Ramified microglial cells actively scan
their environment with their long protrusions [4,5] and
continuous inhibitory signals from neurons prevent micro-
glial toxicity [6,7]. Disconnection of the microglia-neuron
cross-talk [8], local danger signals such as released ATP
[9], or neurotransmitter gradients [10] can lead to a func-
tional transformation of microglial populations with a vari-
ety of effector functions. Consequently, alarmed microglia
and reactive microgliosis have been identified in a variety
of neurodegenerative diseases including Alzheimer’s
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disease [11], Parkinson’s disease [12], amyotrophic lateral
sclerosis [13], multiple sclerosis [14], and inherited photo-
receptor dystrophies [15]. The concept of a microglia-
targeted pharmacotherapy to prevent neurodegeneration
in the brain and the retina is therefore a promising
approach under active investigation [16,17].
There is a growing interest in the identification of nat-
ural compounds that limit neuroinflammation and simul-
taneously support neuronal survival [18,19]. Among the
naturally occuring immuno-modulators, curcumin ((E,
E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-
3,5-dione), a major constituent of tumeric, is a herbal
medicine used for centuries in India and China [20]. Cur-
cumin has a wide range of pharmacological activities
including anti-inflammatory, anti-microbial, antioxidant,
and anti-tumor effects [21]. Curcumin is a particularly
potent immuno-regulatory agent that can modulate the
activation and function of T-cells, B-cells, neutrophils,
natural killer cells and macrophages [22].
Curcumin treatment effectively inhibits the activation of
microglial cells by diminishing the production of nitric
oxide [23] and reducing the secretion of pro-inflammatory
cytokines such as IL1b, IL6 and TNF [24]. Moreover, cur-
cumin blocks the LPS-mediated induction of cyclooxygen-
ase-2 (COX2) via inhibition of the transcription factors
nuclear factor kappa B (NFkB), activator protein 1 (AP1),
and signal transducers and activators of transcription
(STATs) [25,26]. Recent experiments have also demon-
strated that curcumin protects dopaminergic neurons
against microglia-mediated neurotoxicity [27], limits brain
inflammation [28], and rescues retinal cells from stress-
induced cell death [29].
The inhibitory role of curcumin on pro-inflammatory
gene expression in microglia is well documented. How-
ever, this information is limited to only a few well-studied
examples including pro-inflammatory cytokines, Nos2
and COX2. In a genome-wide search for target genes, we
investigated the transcriptomic effects of curcumin in
resting and LPS-activated BV-2 microglial cultures using
DNA-microarrays. Furthermore, we validated the curcu-
min-regulated expression of microglial transcripts with
qRT-PCR and studied the related microglial migration
and neurotoxicity.
Methods
Reagents
Curcumin and E.coli 0111:B4 lipopolysaccharide were pur-
chased from Sigma Aldrich (Steinheim, Germany). Curcu-
min was dissolved in DMSO and added in concentrations
that did not exceed 0.05% of the total volume in any of the
cell culture experiments.
Cell culture
BV-2 microglia-like cells were provided by Professor
Ralph Lucius (Clinic of Neurology, Christian Albrechts
University, Kiel, Germany). BV-2 cells were cultured in
RPMI/5% FCS supplemented with 2 mM L-Glutamine
and 195 nM b-mercaptoethanol. BV-2 cells were stimu-
lated with 100 ng/ml LPS, 20 μM of curcumin, or
DMSO as control for 6 h. These stimulation conditions
were adapted from previously published experiments
[24,30]. MTT assays revealed that 100 ng/ml LPS,
20 μM curcumin, or a combination of both had no cyto-
toxic effects on BV-2 cells (data not shown). 661W
photoreceptor-like cells were a gift from Prof. Muayyad
Al-Ubaidi (University of Illinois, Chicago, IL) and the
culture conditions have been described elsewhere [31].
Scratch assay
500.000 BV-2 cells were grown in 6-well plates as 80%
confluent monolayers and were wounded with a sterile
100 μl pipette tip. Thereafter, the cells were stimulated
with 100 ng/ml LPS, 20 μM of curcumin, 100 ng/ml LPS
+ 20 μM of curcumin, or DMSO as solvent control.
Migration into the open scar was documented with micro-
photographs at different time points after wounding. The
number of migrating cells was quantified by counting all
cells within a 0.4 mm2 region in the center of each scratch.
A minimum of 5 individual cultures was used to calculate
the mean migratory capacity of each cell culture condition.
Transwell migration assay
The Costar Transwell System (8-μm pore size polycarbo-
nate membrane) was used to evaluate vertical cell migra-
tion. 1 Mio BV-2 cells in 1.5 ml serum-free medium were
added to the upper well, and 2.6 ml serum-free medium
was added to the lower chamber. 100 ng/ml LPS, 20 μm
curcumin, 100 ng/ml LPS + 20 μm curcumin, or DMSO
as solvent control were added to the lower chamber med-
ium. At the end of a 24 h incubation period, cells that had
migrated to the lower surface were quantified by counting
the migrated cells on the lower surface of the membrane
using microscopy.
661W co-culture in microglia-conditioned medium and
apoptosis assay
To test microglial neurotoxicity, a culture system of
661W photoreceptors with microglia conditioned med-
ium was established. 661W cells were incubated for 48 h
either in their own medium or with culture supernatants
from unstimulated, 100 ng/ml LPS, 20 μM curcumin, or
100 ng/ml LPS + 20 μM curcumin treated microglial
cells. The 661W cell morphology was assessed by phase
contrast microscopy and apoptotic cell death was deter-
mined with the Caspase-Glo® 3/7 Assay (Promega). Cells
were lysed and incubated with a luminogenic caspase-3/7
substrate, which contains the tetrapeptide sequence
DEVD. Luminescence was then generated by addition of
recombinant luciferase and was proportional to the
amount of caspase activity present. The luminescent
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signal was read on a BMG FluoStar Optima plate reader
(Labtech, Offenburg, Germany). A blank reaction was
used to measure background luminescence associated
with the cell culture system and Caspase-Glo® 3/7
Reagent. The value for the blank reaction was subtracted
from all experimental values. Negative control reactions
were performed to determine the basal caspase activity of
661W cells. Relative luciferase units (RLU) reflect the
level of apoptotic cell death in the different 661W cell
cultures.
RNA isolation and reverse transcription
Total RNA was extracted from cultured microglial cells
according to the manufacturer’s instructions using the
RNeasy Protect Mini Kit (Qiagen, Hilden, Germany). Pur-
ity and integrity of the RNA was assessed on the Agilent
2100 bioanalyzer with the RNA 6000 Nano LabChip®
reagent set (Agilent Technologies, Böblingen, Germany).
The RNA was quantified spectrophotometrically and then
stored at -80°C. First-strand cDNA synthesis was per-
formed with RevertAid™ H Minus First Strand cDNA
Synthesis Kit (Fermentas, St. Leon-Rot, Germany).
DNA-microarray analysis
4 × 44 K microarrays (014868) (Agilent Technologies)
were used for hybridization with three independent
RNAs from non-stimulated BV-2 microglial cells or cul-
tures treated for 6 h with 20 μM curcumin, 100 ng/ml
LPS, or 20 μM curcumin + 100 ng/ml LPS, respectively.
Briefly, 200 ng of total RNA were labeled with Cy3 using
the Agilent Quick-Amp Labeling Kit - 1 color according
to the manufacturer’s instructions. cRNA was purified
with the RNeasy Mini Kit (Qiagen) and labeling efficiency
was determined with a NanoDrop ND-1000 photometer
(PeqLab). The arrays were incubated with cRNAs in
Agilent SureHyb chambers for 17 hours at 65°C while
rotating. After washing, scanning was done with the Agi-
lent G2565CA Microarray Scanner System and the
resulting TIFF files were processed with Agilent Feature
Extraction software (10.7.). Minimum information about
a microarray experiment (MIAME) criteria were met
[32]. The microarray dataset of this study is publicly
available at the National Center for Biotechnology Infor-
mation Gene Expression Omnibus http://www.ncbi.nlm.
nih.gov/geo/ as series record GSE23639.
Bioinformatic data analysis
Integrative analysis of genome-wide expression activities
from BV-2 cells was performed with the Gene Expression
Dynamics Inspector (GEDI), a Matlab (Mathworks,
Natick, MA) freeware program which uses self-organizing
maps (SOMs) to translate high-dimensional data into a 2D
mosaic [33]. Each tile of the mosaic represents an indivi-
dual SOM cluster and is color-coded to represent high or
low expression of the cluster’s genes, thus identifying the
underlying pattern. The Partek Genomics Suite (Partek
Inc.) was used for ANOVA analysis and hierarchical
clustering of normalized expression values. Differentially
regulated transcrips in curcumin-stimulated versus non-
treated and curcumin + LPS versus LPS-treated BV-2
cells, respectively, were retrieved with the Genomatix Chi-
pInspector program (Genomatix Software GmbH,
Munich, Germany), applying the Significance Analysis of
Microarray (SAM) algorithm using a false-discovery rate
of 0.1%.
Quantitative real-time RT-PCR
Amplifications of 50 ng cDNA were performed with an
ABI7900HT machine (Applied Biosystems) in triplicates
in 10 μl reaction mixtures containing 1×TaqMan Univer-
sal PCR Master Mix (Applied Biosystems), 200 nM of pri-
mers and 0.25 μl dual-labeled probe (Roche ProbeLibrary).
The reaction parameters were as follows: 2-min 50°C hold,
30-min 60°C hold, and 5-min 95°C hold, followed by 45
cycles of 20-s 94°C melt and 1-min 60°C anneal/extension.
Measurements were performed in triplicate. Results were
analyzed with an ABI sequence detector software version
2.3 using the ΔΔCt method for relative quantitation. A Ct
(cycle threshold) < 35 was used as cutoff for estimating
significantly expressed transcripts and cDNA samples with
values > 35 were marked with n.e. for not expressed. Ct-
values between 35 and 40 were solely used for calculation
of relative expression differences in treated cells versus
control cells. Primer sequences and Roche Library Probe
numbers are listed in Table 1.
Statistical analyses
Statistical analyses were performed on ΔΔCt data using
the Mann-Whitney Rank Sum test and quantitative
expression data are expressed as mean ± SD plotted at a
logarithmic scale. Gene expression levels in control BV-2
cells were used as calibrators. The Student’s t test or
Mann-Whitney Rank Sum test were used for the compari-
son of experimental groups in cell migration assays and
apoptosis assays as indicated. p < 0.05 was considered
significant.
Results
Curcumin has a major impact on the microglial
transcriptome
To determine the transcriptional profiles of resting and
LPS-activated BV-2 microglial cells after treatment with
20 μM curcumin for 6 h, we performed DNA-microarray
analyses from three independent stimulations. We first
applied the Gene Expression Dynamics Inspector (GEDI)
on the complete dataset to visualize the global patterns of
gene expression in the four different conditions, untreated,
curcumin-treated, LPS-treated, and curcumin + LPS-
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treated cells. GEDI uses self-organizing maps to capture
genome-wide transcriptome activity via ‘gestalt’ recogni-
tion [33]. GEDI facilitates the identification of genome-
wide patterns with each mosaic tile in the map represent-
ing a gene cluster that is expressed at similar levels. The
four GEDI maps, with blue color indicating low and red
color high mRNA expression levels, show a dynamic regu-
lation of gene transcription in the cultured microglial cells
(Figure 1A). The major difference between curcumin-trea-
ted resting microglial cells and control cells was a region
with higher expression at the bottom of the map (Figure
1A, white rectangles). In the LPS-treated condition,
mimicking a highly activated state, curcumin elicited a lar-
gely converse expression pattern with a pronounced area
of weakly expressed genes (Figure 1A, white circles).
These data indicate that curcumin stimulates gene expres-
sion in resting, non-activated cells but mainly dampens
activation-associated transcriptional programs in LPS-
primed microglia.
We next calculated hierarchical clusters of each indivi-
dual microarray dataset after filtering for significantly
altered gene expression using one way ANOVA at p < 0.01.
This analysis showed a clear separation of the four different
conditions with their own characteristic gene expression
profiles (Figure 1B). The clustering revealed two distinct
groups of inversely regulated genes. Group A (Figure 1B)
contains LPS-induced genes, which are no longer up-
regulated in the presence of curcumin. Group B (Figure 1B)
represents genes selectively up-regulated by curcumin
treatment of resting microglial cells. Together with the
GEDI analysis, these results demonstrate that stimulation
with curcumin impacts distinct patterns of gene expression
in resting and LPS-activated microglial cells, respectively.
To narrow down the identified global gene clusters to a
subset of genes with significantly different mRNA
expression in the different curcumin-treated conditions,
we used the Genomatix ChipInspector tool applying the
Significance Analysis of Microarray (SAM) algorithm at a
false discovery rate of 0.1% and a minimum fold change
of 2.0 [34]. Thereby, 35 significantly regulated transcripts
were identified in curcumin-treated versus resting micro-
glial cells (Table 2) and 30 differentially expressed genes
were detected in curcumin + LPS versus LPS-stimulated
cells (Table 3). Comparison of the total numer of differ-
entially expressed transcripts and considering overlap-
ping gene sets revealed that curcumin affects both resting
and LPS-activated BV-2 cells.
qRT-PCR confirmation of novel curcumin target genes in
microglial cells
To validate selected differentially expressed genes identi-
fied by DNA-microarrays, real-time qRT-PCR assays were
performed with RNA samples from three independent
BV-2 stimulation series. We especially focused on genes
which have not been previously shown to be curcumin
targets. In the first set of experiments, mRNA levels of
genes highly up-regulated by curcumin compared to con-
trol cells were assessed (Figure 2). Transcripts of Netrin
G1 (Ntng1), Platelet endothelial cell adhesion molecule 1
(Pecam1), Delta-like 1 (Dll1), Plasma cell endoplasmic
reticulum protein 1 (Perp1), Peroxisome proliferator acti-
vated receptor alpha (PPARa), and Interleukin 4 (Il4) were
all significantly increased by stimulation with curcumin
(Figure 2). Ntng1 showed the strongest expression differ-
ence with a change of more than 1800-fold. Perp1 and
PPARa transcripts were not significantly expressed in rest-
ing microglia and were switched on to intermediate levels
after curcumin treatment (Figure 2). All six transcripts
after combined LPS/curcumin treatment remained simi-
larly high as after curcumin stimulation alone, indicating
Table 1 Primer pairs and Roche library probes for real-time qRT-PCR validation
Gene F-Primer (5’-3’) R-Primer (5’-3’) Roche Library Probe
Atp5b ggcacaatgcaggaaagg tcagcaggcacatagatagcc 77
C3 accttacctcggcaagtttct ttgtagagctgctggtcagg 76
Ccl2 catccacgtgttggctca gatcatcttgctggtgaatgagt 62
Dll1 ttcaactgtgagaagaagatggat gccgaggtccacacactt 103
Egr2 ctacccggtggaagacctc aatgttgatcatgccatctcc 60
Il4 catcggcattttgaacgag cgagctcactctctgtggtg 2
Il6 gatggatgctaccaaactggat ccaggtagctatggtactccaga 6
Nos2 ctttgccacggacgagac tcattgtactctgagggctga 13
Ntng1 aggggcaagagaccaagg agggatggtgtctatcgtcct 103
Pecam1 cggtgttcagcgagatcc cgacaggatggaaatcacaa 45
Perp1 tcatatgccggctcacct atccactggcgtctggagt 110
Ppara ccgagggctctgtcatca gggcagctgactgaggaa 11
Ptgs2 gatgctcttccgagctgtg ggattggaacagcaaggattt 45
Stat1 aaatgtgaaggatcaagtcatgtg catcttgtaattcttctagggtcttga 15
Tlr2 accgaaacctcagacaaagc cagcgtttgctgaagagga 49
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that the effects of curcumin persist in activated microglial
cells.
In the next series of qRT-PCR experiments, down-regu-
lated transcripts known to be involved in pro-inflamma-
tory activation of microglial cells were analyzed. Toll-like
receptor 2 (Tlr2), Early growth response 2 (Egr2), Prosta-
glandin endoperoxide synthase 2 (Ptgs2, alias Cox2), and
Chemokine (C-C-motif) ligand 2 (Ccl2, alias Mcp1)
showed diminished transcript levels in curcumin-treated
resting BV-2 cells (Figure 3A). In the activated state,
microglial cells also had the tendency to expressed lower
amounts of these transcript but only Ccl2 levels reached
the level of statistical significance. When LPS-activated
BV-2 cells were incubated in the presence of curcumin,
transcription of Interleukin 6 (Il6), nitric oxide synthase 2
(Nos2, alias iNos), Signal transducer and activator of tran-
scription 1 (Stat1), and Complement factor C3 (C3) were
all repressed (Figure 3B).
Curcumin has an inhibitory effect on microglial migration
The induction of several transcripts related to cell motility
and adhesion (Ntng1, Pecam1, and Perp1) prompted us to
study the effect of curcumin on microglial migration. We
first cultured BV-2 microglia on plastic dishes until 80%
confluence and then created a scratch with a pipette tip.
12 hours after stimulation of resting microglia or LPS-acti-
vated cells with 20 μM of curcumin, migration into the
cell-free scratch area was documented. Representative
microscopic images clearly showed that curcumin-treated
resting cells as well as activated BV-2 cells exhibit a highly
reduced migratory potential (Figure 4A). The statistical
analysis of five independent experiments revealed a signifi-
cantly reduced number of migrating cells when curcumin
was present in the culture medium (Figure 4B). As an
independent measure of microglial cell motility and to
study the long term effects of curcumin, we performed
transwell migration assays over a period of 24 hours. Simi-
lar as in the scratch assays, the migratory capacity of BV-2
cells was not changed by the activation agent LPS alone
(Figure 4C). In both, the resting and the activated micro-
glial phenotype, curcumin caused a significant attenuation
of microglial migration (Figure 4C). These results indicate
that curcumin-mediated signaling events have functional
consequences related to microglial motility.
Figure 1 Curcumin influences global gene expression in resting and LPS-activated BV-2 microglial cells. (A) Gene Expression Dynamics
Inspector (GEDI) analysis of the complete DNA-microarray dataset from control BV-2 cells or cells treated with 20 μM curcumin, 100 ng/ml LPS,
or 20 μM curcumin + 100 ng/ml LPS for 6 hours. The white rectangles and circles denote the most prominent expression changes in
corresponding gene clusters. (B) Hierarchical clustering of normalized expression levels after one-way ANOVA at p < 0.01. Triplicate microarrays
were analyzed for each condition and the pseudo-color scale indicates high (red) or low (blue) expression levels. LPS and curcumin-related
clusters are marked with A and B, respectively.
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Curcumin inhibits LPS-induced microglial neurotoxicity
To test whether the transcriptomic changes in curcumin-
stimulated cells influence microglial neurotoxicity, 661W
photoreceptor cells were incubated with conditioned med-
ium from BV-2 cells. 661W is a retinoblastoma-derived
cell line, which represents an established model to study
microglial neurotoxicity in the special context of retinal
degeneration [30,31,35]. 661W cells were incubated for
48 h with culture supernatants from unstimulated, curcu-
min-, LPS- or LPS + curcumin-treated BV-2 cells and
661W photoreceptor cell morphology was assessed by
phase contrast microscopy. 661W cells in their own med-
ium grew in a spindle-like shape with only few rounded
apoptotic cells (Figure 5A). Conditioned media from con-
trol- or curcumin-treated microglial cells did not affect
this morphology (Figure 5A). In contrast, 661W cells incu-
bated with LPS-stimulated BV-2 supernatant appeared
apoptotic, leading to larger cell-free areas in the culture
(Figure 5A). When conditioned media from LPS + curcu-
min-stimulated BV-2 cells was used, a nearly normal
Table 2 Differentially expressed transcripts after 6 h
stimulation of BV-2 cells with 20 μM curcumin
Nr ID Symbol Gene Name FC
UP-REGULATED
1 80883 Ntng1 Netrin G1 313.0
2 18613 Pecam1 Platelet/endothelial cell adhesion
molecule 1
42.8
3 13388 Dll1 Delta-like 1 35.5
4 12824 Col2a1 Collagen, type II, alpha 1 21.6
5 14103 Fasl Fas ligand (TNF superfamily, member 6) 12.8
6 12653 Chgb Chromogranin B 11.9
7 66184 Rps4y2 Ribosomal protein S4, Y-linked 2 9.7
8 69816 Perp1 RIKEN cDNA 2010001M09 gene 9.7
9 16992 Lta Lymphotoxin A 9.4
10 19206 Ptch1 Patched homolog 1 5.9
11 19013 Ppara Peroxisome proliferator activated receptor
alpha
4.6
12 109685 Hyal3 Hyaluronoglucosaminidase 3 4.5
13 20997 T Brachyuri 4.2
14 17246 Mdm2 Transformed mouse 3T3 cell double
minute 2
3.1
15 14102 Fas Fas 2.8
16 14183 Fgfr2 Fibroblast growth factor receptor 2 2.7
17 13645 Egf Epidermal growth factor 2.2
18 14179 Fgf8 Fibroblast growth factor 8 2.1
19 20655 Sod1 Superoxide dismutase 1 2.1
20 14526 Gcg Glucagon 2.0
DOWN-REGULATED
1 24088 Tlr2 Toll-like receptor 2 -6.9
2 18505 Pax3 Paired box gene 3 -6.6
3 14281 Fos FBJ osteosarcoma oncogene -4.4
4 11622 Ahr Aryl-hydrocarbon receptor -4.1
5 16835 Ldlr Low density lipoprotein receptor -3.8
6 13654 Egr2 Early growth response 2 -3.5
7 68010 Bambi BMP and activin membrane-bound
inhibitor
-3.3
8 12048 Bcl2l1 BCL2-like 1 -3.3
9 19225 Ptgs2 Prostaglandin-endoperoxide synthase 2 -3.0
10 20296 Ccl2 Chemokine (C-C motif) ligand 2 -2.8
11 12393 Runx2 Runt related transcription factor 2 -2.8
12 17311 Kitl Kit ligand -2.4
13 16869 Lhx1 LIM homeobox protein 1 -2.4
14 12977 Csf1 Colony stimulating factor 1 -2.4
15 20528 Slc2a4 Solute carrier family 2, member 4 -2.2
Significance analysis of triplicate microarrays was performed with a false
discovery rate of 0.1%. ID, Entrez Gene ID; FC: Fold change.
Table 3 Differentially expressed transcripts after 6 h
stimulation with 20 μM curcumin + 100 ng/ml LPS versus
100 ng/ml LPS
Nr ID Symbol Gene Name FC
UP-REGULATED
1 80883 Ntng1 Netrin G1 86.2
2 18613 Pecam1 Platelet/endothelial cell adhesion
molecule 1
11.7
3 12824 Col2a1 Collagen, type II, alpha 1 9.0
4 12653 Chgb Chromogranin B 8.1
5 14103 Fasl Fas ligand (TNF superfamily, member 6) 6.9
6 19206 Ptch1 Patched homolog 1 6.5
7 69816 Perp1 RIKEN cDNA 2010001M09 gene 5.4
8 14526 Gcg Glucagon 5.0
9 109685 Hyal3 Hyaluronoglucosaminidase 3 4.1
10 16189 Il4 Interleukin 4 3.8
11 20655 Sod1 Superoxide dismutase 1 3.5
12 19013 Ppara Peroxisome proliferator activated receptor
alpha
3.1
13 20997 T Brachyuri 2.6
14 640627 Gm9789 ENSMUSG00000044227 2.6
15 16147 Ihh Indian hedgehog homolog 2.6
16 17246 Mdm2 Transformed mouse 3T3 cell double
minute 2
2.5
17 99439 Duox1 Dual oxidase 1 2.3
18 257956 Olfr1307 Olfactory receptor 1307 2.3
19 14179 Fgf8 Fibroblast growth factor 8 2.1
DOWN-REGULATED
1 16193 Il6 Interleukin 6 -93.1
2 18126 Nos2 Nitric oxide synthase 2 -55.7
3 19225 Ptgs2 Prostaglandin-endoperoxide synthase 2 -17.6
4 20296 Ccl2 Chemokine (C-C motif) ligand 2 -14.7
5 12266 C3 Complement C3 -9.1
6 20846 Stat1 Signal transducers and activator of
transcription 1
-7.4
7 12048 Bcl2l1 BCL2-like 1 -5.4
8 14281 Fos FBJ osteosarcoma oncogene -4.6
9 16835 Ldlr Low density lipoprotein receptor -4.1
10 16992 Lta Lymphotoxin A -3.5
11 17395 Mmp9 Matrix metallopeptidase 9 -2.2
Significance analysis of triplicate microarrays was performed with a false
discovery rate of 0.1%. ID, Entrez Gene ID; FC: Fold change.
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Figure 2 Curcumin induces genes related to adhesion and anti-inflammatory response. Real-time qRT-PCR validation of transcripts in BV-2
microglia stimulated with 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 6 hours. Relative mRNA levels were
quantified for Netrin G1 (Ntng1), Platelet endothelial call adhesion molecule 1 (Pecam1), Delta-like 1 (Dll1), Plasma cell induced endoplasmic
reticulum protein 1 (Perp1), Peroxisome proliferator activated receptor a (PPARa), and Interleukin 4 (Il4). Expression was normalized to the control
gene Atp5b and mRNA levels (+/- SD) are graphed relative to control cells. Results are calculated from three independent experiments
performed in triplicate measurements. * p ≤ 0.05, *** p ≤ 0.001 for curcumin vs. control, Mann-Whitney Rank Sum test. n.e., not expressed.
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661W cell morphology was retained (Figure 5A). Direct
incubation of 661W cells with curcumin, LPS, or both had
no effects on the cell cultures (data not shown), demon-
strating that the observed changes in 661W cell character-
istics stem from secreted microglial compounds.
To corroborate these morphological findings with
further functional data, we analyzed the influence of
microglia-derived products on caspase-related apoptotic
cell death. 661W cells cultured with supernatants from
LPS-stimulated BV-2 cells showed a significant induction
of caspase 3/7 activity (Figure 5B). When using condi-
tioned media from microglial cells co-treated with LPS +
curcumin, 661W apoptosis was still present but was sig-
nificantly diminished (Figure 5B). These data clearly
implicate that curcumin may limit the production of pro-
apoptotic compounds in activated microglial cells or
even promote the release of neurotrophic factors.
Discussion
Oxidative stress and neuroinflammation are major factors
in the pathogenesis of neurodegenerative disorders [36].
Therefore, antioxidant and anti-inflammatory compounds
like curcumin may be treatment options for this group of
diseases [37]. However, only few experimental data are
available that report on curcumin-triggered transcriptional
mechanisms and direct signaling targets in microglia.
Our transcriptomic analysis in BV-2 cells sheds some
light on target genes and potential signaling mechanisms.
We identified a prominent transcriptional response of
resting as well as LPS-activated microglial cells after curcu-
min treatment. Distinct gene clusters were detected that
reflect up-regulated and suppressed transcripts in both
microglial phenotypes. We identifed and validated six genes
that were constistently induced in resting as well as acti-
vated BV-2 cells that have not been described as curcumin
targets before. Among these, four curcumin target genes
are related to cell migration. Netrin G1 is a lipid-anchored
protein that is structurally related to the netrin family of
axon guidance molecules [38]. It regulates synaptic interac-
tions between neurons by binding to transmembrane netrin
G ligands [39]. Interestingly, the related Netrin 1 molecule
is a broad inhibitor of leukocyte chemotaxis [40] and Netrin
G1 may have a similar function in microglia. The adhesion
molecule PECAM1 is also directly involved in monocyte/
macrophage migration [41]. Another migration-related
gene induced by curcumin is Plasma cell endoplasmic reti-
culum protein 1. PERP 1 is a molecular chaperone required
for proper folding and secretion of immunoglobulins in B-
cells [42,43]. Related to our study, a recent report linked
PERP 1 (alias MZB1) to calcium signaling, activation of
integrins and cell adhesion [44]. Expression of the Notch-
ligand Delta-like 1 has been demonstrated in BV-2 cells
and primary rat brain microglial cells, where Notch-1 sig-
naling negatively regulates TNF release [45]. Our data show
that basal Dll1 expression in resting microglial cells can be
potently induced by curcumin, which could potentially trig-
ger Notch-signaling to prevent migration associated with
pro-inflammatory priming of BV-2 cells.
Figure 3 Curcumin potently blocks pro-inflammatory gene expression. Real-time qRT-PCR validation of transcripts in BV-2 microglia
stimulated with 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 6 hours. Relative mRNA levels were quantified for (A)
Toll-like receptor 2 (Tlr2), Early growth response 2 (Egr2), Prostaglandin endoperoxide synthase 2 (Ptgs2), Chemokine ligand 2 (Ccl2), and (B)
Interleukin 6 (Il6), Nitric oxide synthase 2 (Nos2, alias iNos), Signal transducer and activator of transcription 1 (Stat1), Complement C3 (C3).
Expression was normalized to the control gene Atp5b and mRNA levels (+/- SD) are graphed relative to control cells. Results are calculated from
three independent experiments performed in triplicate measurements. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 for curcumin vs. control, and # p ≤
0.05, ## p ≤ 0.01 for curcumin + LPS vs. LPS, Mann-Whitney Rank Sum test.
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These transcriptomic data of curcumin-treatment pro-
moted us to analyze its effects on microglial motility.
Both types of assays, the wound healing assays and the
transwell migration experiments, showed that BV-2 cell
migration was significantly inhibited by 20 μM curcumin
over a period of 12 hours to 24 hours. These findings are
in good agreement with papers reporting reduced migra-
tion of tumor cells, endothelial cells, and dendritic cells
after treatment with comparable doses of cucumin
[46-48]. In the homeostatic state, microglia constantly
scan their environment with their long protrusions with-
out movement of the somata [5]. In contrast, migration
of microglial cells is a hallmark of pro-inflammatory and
chronic activation during early phases of neurodegenera-
tion. Thus, curcumin may support the homeostatic state
of microglia and prevent their early and excessive trans-
formation into migrating phagocytes.
It is well known that curcumin broadly inhibits pro-
inflammatory gene expression by targeting different sig-
nal pathways and transcriptional regulators including
NFkB, AP1, EGR1, and STAT3 [49]. Our microarray data
corroborate these findings especially in LPS-activated
BV-2 cells by showing curcumin-triggered suppression of
Ptgs2, Ccl2, Il6, and Nos2, which are NFkB, AP1, and
STAT3 target genes [21]. Moreover, the curcumin-regu-
lated transcriptomic profiles revealed lower gene expres-
sion of toll-like receptor 2 in resting microglia and
complement factor 3 in activated cells. These two factors
broadly support the conversion of microglial cells to the
pro-inflammatory state [50,51] and hence curcumin sig-
naling may abrogate both pathways. Our data also
showed diminished mRNA expression of the transcrip-
tion factors Egr2 and Stat1 following curcumin-treat-
ment. This indicates that curcumin may further dampen
microglial activation by interfering with two other key
transcription factors expressed in activated microglial
cells. In addition to its inhibitory effects on pro-inflam-
matory signaling, two well known anti-inflammatory
molecules, PPARa and IL4, were significantly induced by
curcumin. PPARa and IL4 both specifically inhibit pro-
inflammatory activation of microglial cells [52,53] and
some of the immune-dampening effects of curcumin may
be mediated via this signaling axis.
The cell culture experiments with conditioned media
from BV-2 cells showed that curcumin significantly
reduced LPS-triggered microglial neurotoxicity on 661W
photoreceptor cells. We hypothesize that the strong sup-
pression of LPS-induced Nos2 transcription by curcumin
Figure 4 Curcumin reduces microglial migration. (A, B) Scratch assays in BV-2 microglia treated with solvent control, 20 μM curcumin, 100
ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS for 12 hours. (A) Micrographs from one representative experiment out of five independent
experiments are shown. (B) Results of scratch assayss are calculated mean values ± SEM from five independent experiments. (C) Transwell
chamber migration of BV-2 microglial cells treated with solvent control, 20 μM curcumin, 100 ng/ml LPS, or 20 μM curcumin + 100 ng/ml LPS
for 24 hours. The absolute number of migrating cells was counted in the lower chamber and mean values ± SEM are displayed. p ≤ 0.05 for
curcumin vs. control, and # p ≤ 0.05 for curcumin + LPS vs. LPS, Student’s t test.
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is a major pathway responsible for this phenomenon. In
this context, Mandal et al. have recently demonstrated
that curcumin protects 661W cells from hydrogen perox-
ide-induced cell death [29]. This effect is very likely
mediated by the antioxidant and radical-scavenging capa-
city of curcumin. In a model of light-induced retinal
degeneration, curcumin also suppressed inflammatory
marker expression in vivo [29], which could be potentially
mediated by its attenuating effect on retinal microglia.
Conclusions
We have shown that curcumin triggered global changes
in the transcriptome of resting and LPS-activated micro-
glial cells. In addition to its known function in blocking
pro-inflammatory gene expression via interference with
NFkB signaling, curcumin induced novel anti-inflamma-
tory targets in microglia. Curcumin also significantly
inhibited microglial migration and cytotoxicity, which
are key features of neuroinflammation. Our publicily
avialable dataset provides a basis to understand the
pleiotropic beneficial effects of curcumin on microglia
as key innate immune cells of the nervous system.
Moreover, the results of this study also underscore the
importance of curcumin as a promising dietary com-
pound for the treatment of various neurodegenerative
disorders associated with inflammation.
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